Showing results (1191-1200 of 4,634) with videos related to
Sort By:
Pageof 464
Anti-Cancer Drugs|December 14, 2011
Sorafenib, but not sunitinib, induces regulatory T cells in the peripheral blood of patients with metastatic renal cell carcinomaAnne Flörcken, Anna Takvorian, Antje Van Lessen, et al.Anti-Cancer Drugs|December 14, 2011
Treatment for recurrent medulloblastoma with intrathecal liposomal cytarabine and systemic metronomic combination therapyRandi Nygaard, Sanna-Maria KivivuoriAnti-Cancer Drugs|February 9, 2012
Effects of lobaplatin as a single agent and in combination with TRAIL on the growth of triple-negative p53-mutated breast cancers in vitroJörg B Engel, Theresa Martens, Jens C Hahne, et al.Anti-Cancer Drugs|February 21, 2012
Preparation, characterization, and assessment of the antiglioma effects of liposomal celastrolYulun Huang, Dai Zhou, Taijun Hang, et al.Anti-Cancer Drugs|January 17, 2012
Arsenic trioxide induces cervical cancer apoptosis, but specifically targets human papillomavirus-infected cell populationsXuesong Wen, Dong Li, Yunyan Zhang, et al.Anti-Cancer Drugs|January 14, 2012
Ampelopsin sodium exhibits antitumor effects against bladder carcinoma in orthotopic xenograft modelsBaolai Zhang, Shuhong Dong, Xiaobo Cen, et al.Anti-Cancer Drugs|March 21, 2012
J-4: a novel and typical preclinical anticancer drug targeting protein kinase C ζHongyan Li, Jing Wu, Guoguang Ying, et al.Anti-Cancer Drugs|December 22, 2011
Antiproliferative effects of artemisinin on human breast cancer cells requires the downregulated expression of the E2F1 transcription factor and loss of E2F1-target cell cycle genesAntony S Tin, Shyam N Sundar, Kalvin Q Tran, et al.Anti-Cancer Drugs|April 7, 2012
A phase II study of modified FOLFOX as first-line chemotherapy in advanced small bowel adenocarcinomaXiao Jun Xiang, Ya Wen Liu, Ling Zhang, et al.Anti-Cancer Drugs|July 7, 2011
Extracelluar matrix metalloproteinase as a novel target for pancreatic cancer therapyHyunki Kim, Guihua Zhai, Zhiyong Liu, et al.Pageof 464